0001214659-22-004992.txt : 20220408
0001214659-22-004992.hdr.sgml : 20220408
20220408170023
ACCESSION NUMBER: 0001214659-22-004992
CONFORMED SUBMISSION TYPE: 4/A
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20220328
FILED AS OF DATE: 20220408
DATE AS OF CHANGE: 20220408
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: McGrath Lynne Fahey
CENTRAL INDEX KEY: 0001866270
FILING VALUES:
FORM TYPE: 4/A
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-40483
FILM NUMBER: 22817718
MAIL ADDRESS:
STREET 1: 28145 CEDAR POINT RD.
CITY: EASTON
STATE: MD
ZIP: 21601
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Alzamend Neuro, Inc.
CENTRAL INDEX KEY: 0001677077
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 811822909
STATE OF INCORPORATION: DE
FISCAL YEAR END: 0430
BUSINESS ADDRESS:
STREET 1: 3802 SPECTRUM BLVD,
STREET 2: SUITE C112C
CITY: TAMPA
STATE: FL
ZIP: 33612
BUSINESS PHONE: 844-722-6333
MAIL ADDRESS:
STREET 1: 3802 SPECTRUM BLVD,
STREET 2: SUITE C112C
CITY: TAMPA
STATE: FL
ZIP: 33612
4/A
1
marketforms-55978.xml
PRIMARY DOCUMENT
X0306
4/A
2022-03-28
2022-04-06
0001677077
Alzamend Neuro, Inc.
ALZN
0001866270
McGrath Lynne Fahey
3500 LENOX RD NE, SUITE 1500
ATLANTA
GA
30326
true
false
false
false
Common Stock
2022-03-28
4
S
false
25000
1.213
D
75000
D
The original Form 4 filed on April 6, 2022, is amended by this Form 4 amendment to correct a typographical error in Table I Column 4 from "A" to "D".
The common stock was sold by the Reporting Person in open market transactions on the transaction date, with a volume weighted average purchase price of $1.213. The range of sale prices on the transaction date was $1.19 to $1.23 per share. The reporting person undertakes to provide, upon request by the SEC staff, the issuer, or a security holder of the issuer, full information regarding the number of shares sold at each price.
/s/ Lynne F. McGrath
2022-04-08